{"disease":{"id":"lymphocytic-lymphoma-moxetumomab-pasudotox","name":"lymphocytic lymphoma moxetumomab pasudotox"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00587457","title":"A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"MedImmune LLC","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}